First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

527 Reviews

Credit Rating - AMERICAN BIOCHEMICAL AND PHARMACEUTICALS LIMITED

ANALYSIS
Credit Risk Update: AMERICAN BIOCHEMICAL AND PHARMACEUTICALS LIMITED, SUITE 1B1 ARGYLE HOUSE, NORTHSIDE, JOEL STREET, NORTHWOOD, MIDDLESEX, HA6 1NW. The legal status is a Private Limited Company and the current status at the registry of companies is Active. The last filed accounts are dated 30 September 2023. The company was incorporated on 23 June 1995.

The accounts next due date is 30 June 2025. There are no mortgages.

The above was based on public record information as at 28 October 2024 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 03071923
Date Incorporated: 23 June 1995
Date Latest Accounts: 30 September 2023
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: None
Registered Number: 03071923
Annual Return: 31 May 2016
Registered Office: SUITE 1B1 ARGYLE HOUSE, NORTHSIDE, JOEL STREET, NORTHWOOD, MIDDLESEX, HA6 1NW
SIC Code and Operations: 46460
SECURED CREDITORS
Number of Mortgages 0
Satisfied Mortgages 0
Part Satisfied Mortgages 0
Unsatisfied Mortgages 0
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

AMERICAN BIOCHEMICAL AND PHARMACEUTICALS LIMITED

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 7 November 2024 Copyright © 2024 First Report Ltd


Recent Searches

Reg No. Reg Name Status
09223867 AMERICAN BIOCURE LIMITED Active
09099495 AMERICAN BITES LTD Active
14065175 AMERICAN BLUES LTD Active
13843816 AMERICAN BOARD UK LTD Active
09561108 AMERICAN BRAND NAMES LIMITED Dissolved

In using this service you agree to the Terms and Conditions

© 2024 First Report Ltd